Research Article

LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease

Figure 3

Correlation of the plasma LncRNA LUCAT1 and clinical parameters in the patients with CD. (a) The relative expression of LUCAT1 in male/female patients. (b) The relative expression of LUCAT1 in patients related to the location at L1/L2/L3. (c) The relative expression of LUCAT1 in in patients related to the disease behaviors at B1/B2/B3. (d) The relative expression of LUCAT1 in patients with mild/moderate/severe CD and in controls. .
(a)
(b)
(c)
(d)